SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem - Quaterly Results

19 Jan 2023 Evaluate
The sales for the December 2022 quarter moved up 27.40% to Rs. 5378.42 millions as compared to Rs. 4221.74 millions during the corresponding quarter last year.The Company has registered profit of Rs. 771.97  millions for the quarter ended December 2022, a growth of 10.70%  over Rs. 697.34 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 1662.67 millions from the corresponding previous quarter of 1410.71 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 5378.42 4221.74 27.40 16262.22 10521.45 54.56 15509.41 8286.00 87.18
Other Income -2.61 -2.96 -11.82 34.45 21.40 60.98 41.11 21.89 87.80
PBIDT 1662.67 1410.71 17.86 5377.30 3365.21 59.79 5135.97 2635.17 94.90
Interest 210.31 103.56 103.08 465.14 324.55 43.32 442.70 291.14 52.06
PBDT 1452.36 1307.15 11.11 4912.16 3040.66 61.55 4693.27 2344.03 100.22
Depreciation 308.39 218.15 41.37 788.24 648.42 21.56 859.06 735.45 16.81
PBT 1143.97 1089.00 5.05 4123.92 2392.24 72.39 3834.21 1608.58 138.36
TAX 372.00 391.66 -5.02 1358.34 855.26 58.82 1306.36 600.19 117.66
Deferred Tax 165.14 192.59 -14.25 616.09 416.52 47.91 609.63 318.51 91.40
PAT 771.97 697.34 10.70 2765.58 1536.98 79.94 2527.85 1008.39 150.68
Equity 415.50 415.50 0.00 415.50 415.53 -0.01 415.50 415.53 -0.01
PBIDTM(%) 30.91 33.42 -7.49 33.07 31.98 3.38 33.12 31.80 4.13

Epigral Share Price

1063.65 -48.70 (-4.38%)
11-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2658.95
BASF India 3253.95
Tata Chemicals 741.00
Pidilite Inds. 1498.80
Deepak Nitrite 1611.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: